Bridgitte Lee
Optometrist · Houston, TXNPI 1114017175
Payments from drug & device makers
Across 833 payments — averaging $3645.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tarsus Pharmaceuticals, Inc.$2.7M
- Johnson & Johnson Vision Care, Inc.$93K
- Sun Pharmaceutical Industries Inc.$82K
- Bausch & Lomb Americas Inc.$41K
- Lumenis BE Inc$16K
- Dompe US, Inc.$13K
- plus $61K from 21 others
Across 7 payments — averaging $27,041 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tarsus Pharmaceuticals, Inc.$148K
- Johnson & Johnson Vision Care, Inc.$36K
- Novartis$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 81 | $2,730,596 |
| Johnson & Johnson Vision Care, Inc. | 114 | $93,445 |
| Sun Pharmaceutical Industries Inc. | 155 | $81,649 |
| Bausch & Lomb Americas Inc. | 121 | $40,763 |
| Lumenis BE Inc | 4 | $16,129 |
| Dompe US, Inc. | 45 | $13,489 |
| Alcon | 73 | $13,048 |
| Alcon Research LLC | 16 | $10,750 |
| Kala Pharmaceuticals, Inc. | 12 | $8,817 |
| Lumenis, Inc | 7 | $8,055 |
| Coopervision Inc. | 62 | $7,362 |
| Johnson & Johnson Surgical Vision, Inc. | 13 | $4,992 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 32 | $2,235 |
| Shire North American Group Inc | 12 | $1,204 |
| Biotissue Holdings Inc. | 6 | $1,051 |
| Lumenis Ltd. | 1 | $750 |
| Visioneering Technologies, Inc. | 6 | $518 |
| AbbVie(2 entities) | 19 | $492 |
| Novartis | 20 | $490 |
| Oyster Point Pharma, Inc. | 18 | $419 |
| Carl Zeiss Meditec, Inc. | 1 | $350 |
| Harrow Eye, LLC | 7 | $185 |
| Optos, Inc. | 3 | $108 |
| Eyevance Pharmaceuticals LLC | 2 | $49 |
| Mylan Inc. | 1 | $46 |
| Carl Zeiss Meditec USA, Inc. | 1 | $22 |
| Thea Pharma Inc. | 1 | $18 |
How this compares
$3,037,030 in reported general payments places this provider in the 95th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in Houston
- Tiffany HuynhHouston$3.2M
- Phillip BrunsonHouston$766K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$568K
- Kathryn RichdaleHouston$288K
- Nancy StephensHouston$241K
- Jelita Green-DathorneHouston$232K
- Eric RitcheyHouston$151K
- Maria WalkerHouston$128K
- Erin TomiyamaHouston$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.